Exome Asset Management »

Establishment Labs Holdings Ord shares owned by Exome Asset Management

Quarter-by-quarter ownership of Establishment Labs Holdings Ord (ESTA) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Establishment Labs Holdings Ord

Tip: Access up to 7 years of quarterly data

All positions including Establishment Labs Holdings Ord held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Establishment Labs Holdings Ord by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $939k 22k 43.27
2024-06-30 $986k 22k 45.44
2023-12-31 $715k 28k 25.89

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bridgebio Pharma (BBIO)
Structure Therapeutics Sponsored Ads (GPCR)
Tg Therapeutics (TGTX)
Align Technology (ALGN)
Cigna Corp (CI)
Gilead Sciences (GILD)
Geron Corporation (GERN)
Biontech Se Sponsored Ads (BNTX)
Bristol Myers Squibb (BMY)
Miragen Therapeutics (VRDN)
Intuitive Surgical Com New (ISRG)
Beigene Sponsored Adr
Blueprint Medicines (BPMC)

View all positions for Exome Asset Management

Top funds holding Establishment Labs Holdings Ord

JW Asset Management
Rtw Investments
Brown Advisory Holdings Incorporated
Capital Research Global Investors
Nantahala Capital Management
Summit Partners Public Asset Management
Findell Capital Management
Morgan Stanley
William Blair Investment Management
Rice Hall James & Associates
Bamco
Millennium Management
Balyasny Asset Management
Jpmorgan Chase & Co
Polar Capital Holdings

View all funds holding Establishment Labs Holdings Ord